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Phaeohyphomycosis is a heterogeneous group
of opportunistic infections that are becoming
increasingly more prevalent as pathogens in immu-
nocompromised individuals. We present a rare case
of cutaneous phaeohyphomycosis caused by
Biatriospora mackinnonii in a renal transplant
patient. This case also highlights the importance
of molecular techniques in the diagnosis of this rare
disease.
CASE REPORT
A 65-year-old Mexican-American woman was
evaluated in the dermatology department for a right
forearm cutaneous lesion. Her medical history was
significant for diabetes and hypertension leading to
end-stage renal disease. The patient underwent
cadaveric renal transplant 5 months earlier and was
currently taking tacrolimus and mycophenolic acid.
Approximately 3 months before her presentation,
she noted the rapid onset of a painless papule on her
right distal forearm that subsequently progressed
insidiously into a large nodule. It was subsequently
drained as a presumed hematoma, and she
completed a short course of cephalexin. She then
traveled to Colima, Mexico. During the trip she
denied outdoor exposures but did admit to
attempting to drain the lesion at home using insulin
needles. Upon returning to the United States, the
lesion was drained again as a presumed hematoma,
and she completed a course of clindamycin without
improvement. A radiograph of her forearm and wrist
at that time showed soft tissue swelling without
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60612. E-mail: tsoukasm@uic.edu.examination found a 5- 3 5-cm symmetric dome-
shaped exophytic nodule located on her right fore-
arm with a diffuse overlying hemorrhagic eschar that
was easily removed revealing underlying pink friable
tissue (Fig 1). A rim of erythema surrounded this
lesion. No lymphadenopathy was appreciated.
Punch biopsy skin specimens were obtained for
both tissue culture and histology. Hematoxylin and
eosinestained slides showed dermal involvement by
fungal hyphal elements, marked irregular pseudoe-
pitheliomatous hyperplasia of the epidermis, and
moderate-to-severe acute and chronic dermal
inflammation with microabscesses (Fig 2). There
was an absence of granules, and no sclerotic bodies
were noted. Periodic acid-Schiff and Gomori
methenamine silver stains found the fungal elements
to be predominantly in the mid to reticular dermis,
and Fontana-Masson staining confirmed this finding
(Fig 3).
Tissue culture recovered a velvety dark grey mold
with a dark reverse after 10 days of incubation (Fig
4). Microscopic examination found septate hyphae
but no other identifying structures (ie, conidia). DNA
sequencing of the internal transcribed spacer and
D1/D2 regions of the ribosome was performed and
identified the organism as B mackinnonii (formerly
Pyrenochaeta mackinnonii). Cultures for acid-fast
bacilli were negative, but bacterial culture grew
many pan-susceptible Klebsiella pneumoniae.
Histoplasma antigen and blastomyces antibody
were not detected, and a complete blood count
with differential was within normal limits. Chest
radiograph was nonrevealing. Magnetic resonance
imaging of the right forearm showed a large T1/T2JAAD Case Reports 2016;2:230-2.
2352-5126
 2016 by the American Academy of Dermatology, Inc. Published
by Elsevier, Inc. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
http://dx.doi.org/10.1016/j.jdcr.2016.03.015
Fig 1. Cutaneous phaeohyphomycosis caused by B
mackinnonii. Exophytic nodule with overlying eschar
on dorsal forearm/wrist.
Fig 2. Hematoxylin-eosin staining shows exuberant pseu-
doepitheliomatous hyperplasia of the epidermis with
dense acute and chronic dermal inflammation.
Fig 3. Fontana-Masson staining shows septate hyphae
within the dermis.
Fig 4. Growth of B mackinnonii on Remel Inhibitory
Mold Agar incubated at 288C for 10 days.
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skin. The patient was started on itraconazole with a
known interaction with tacrolimus requiring close
monitoring and a decrease in tacrolimus dosing.
After 2 weeks of pretreatment with itraconazole,
200 mg twice daily, the lesion was excised, and a
split-thickness skin graft was used to close the
surgical site. She was continued on itraconazole to
complete a 6-month course. After 8 months of close
postoperative follow-up, there is no evidence of
recurrence.
DISCUSSION
The term phaeohyphomycosiswas first introduced
by Ajello et al1 in 1974 to describe infections caused
by dark-walled, also known as dematiaceous or
melanized, fungi that are clinically, pathologically,
and mycologically distinct from classic chromoblas-
tomycosis. In 1983, phaeohyphomycosis was further
subclassified by McGinnis2 into 4 clinical presenta-
tions: superficial, cutaneous and corneal, subcutane-
ous, and systemic. Recent advances in molecular
techniques led to the ability to rapidly and accurately
speciate nonsporulating melanized molds. This
finding is very important, as different species may
have tropism for different organs and varying sus-
ceptibilities to antifungals.3 Gene sequencing of theinternal transcribed spacer region remains one of the
most widely acceptedmolecular methods because of
its ability to discriminate between inter- and intra-
species variations, a high polymerase chain reaction
amplification success rate, and enriched datasets
deposited in many gene banks.3 Using gene
sequencing we identified B mackinnonii as the
causative species in this case. In a recent phyloge-
netic study, Pyrenochaeta mackinnonii was accom-
modated into the new genus Nigrograna as
Nigrograna mackinnonii.4 Subsequently, the classi-
fication was revised again and the genus Nigrograna
was reduced to the synonym of Biatriospora—thus
the most current nomenclature for this species is B
mackinnonii. To our knowledge, this species has
only been implicated in one case of phaeohypho-
mycosis to date.3 There have been two cases in the
literature describing this species as the causative
agent of eumycotic mycetoma.4 Until recently, many
reported cases of phaeohyphomycosis did not
include the causative species or did so based on
descriptions of the macroscopic and microscopic
morphology. Thus, the true prevalence of this and
other species implicated in phaeohyphomycosis
may be understated because of lack of and unreli-
ability of nonmolecular strain identification
methods. The histologic criterion for diagnosis of
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dematiaceous mycelia.5,6
There are no standardized treatment protocols for
the treatment of phaeohyphomycosis but voricona-
zole, posaconazole, and itraconazole show the most
consistent in vitro activity against this group of
fungi.7 Oral itraconazole is considered the empiric
drug of choice given the most clinical experience
with this drug in the literature.8 For cutaneous
nodules in particular, surgery alone has been effec-
tive inmany cases, but oral antifungals are often used
as co-adjunctive therapies especially in immunosup-
pressed patients to prevent dissemination.7
Biatriospora is a genus that is widely distributed in
soil, on wood, and other plant debris and as plant
pathogens.9 Phaeohyphomycosis is often preceded
by a history of trauma, but the role of injury in this
case is unclear. Although cutaneous phaeohypho-
mycosis is a rare entity, there should be a high index
of suspicion in renal transplant recipients presenting
with pigmented skin lesions to allow for timely
diagnosis and management.
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